How to Plan for GLP-1 Medications in 2025 and Beyond

EPIC

Employers struggle with rising healthcare costs, and GLP-1 medications are a significant contributor. These powerful drugs for patients with diabetes and obesity come at a price tag exceeding $10,000 per patient annually. But there is hope!

Discover how to optimize the use of GLP-1s in your pharmacy program.

Join our webinar on Thursday, August 22, at 2:00 p.m. ET. Our panel of seasoned pharmacists – Laura Matarazzo, RPh, Vice President, Middle Market Plan Sponsor Consulting, and Sarah Fleming, PharmD, Senior Pharmacy Benefit Clinical Consultant – will be moderated by Morgan Lee, PhD, MPH, CPH, Senior Director, Research & Strategy at PSG.

What You’ll Learn:

• When GLP-1s are the right choice: Learn how to distinguish between situations where GLP-1s are most beneficial or lower-cost alternatives are effective for diabetes treatment.
• Strategies for smart utilization: Discover practical utilization management techniques to ensure the right patients get GLP-1s for the intended diagnoses. We’ll also cover how to optimize coverage for patients with obesity.
• The future of GLP-1s: Gain insights into the upco

More Information, How to Register